Pursuant to Articles 1116, 1117 and 1119 of the North American Free Trade Agreement1 and with a view to resolving this dispute amicably through the consultations and negotiations contemplated by NAFTA Article 1118, the disputing investor Eli Lilly and Company respectfully serves the Government of Canada with this Notice of Intent to Submit a Claim to Arbitration under Chapter Eleven of the NAFTA.

I. NAMES AND ADDRESS OF DISPUTING INVESTOR AND ITS ENTERPRISE

1. Eli Lilly and Company is a corporation organized under the laws of the State of Indiana, United States of America, and thus is an enterprise of a Party (the United States) pursuant to NAFTA Article 1139. The registered address for Eli Lilly and Company is:

Lilly Corporate Center

Indianapolis, Indiana 46285 USA

2. Eli Lilly and Company submits this Notice of Intent to Submit a Claim to Arbitration both under NAFTA Article 1116 as an investor on its own behalf, and under NAFTA Article 1117 on behalf of an enterprise that it owns or controls directly or indirectly: Eli Lilly Canada Inc.

3. Eli Lilly Canada Inc., a corporation organized under the laws of Canada (the Business Corporations Act) is a wholly owned subsidiary of Eli Lilly and Company. The principal place of business for Eli Lilly Canada Inc. is: